INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Highlands]( "Increasing Participation In World-Class Cancer Research In Northwest Arkansas")
Increasing Participation In World-Class Cancer Research In Northwest ArkansasDiscover how data automation and integrated screening help community cancer centers offer clinical research as a standard care option, ensuring all patients have access to the latest treatments.
-
![doctor and patient consultation-GettyImages-2101007339]( "Breaking Barriers In Drug Development: Time, Trust And Putting Patients First")
Breaking Barriers In Drug Development: Time, Trust And Putting Patients FirstUnpack systemic challenges in drug development that inflate costs and delay life-saving treatments. Learn about streamlining processes, fostering patient trust, and reallocating resources efficiently.
-
![GettyImages-1759287088 patient nurse consultation]( "Does 'The Belmont Report' Provide Guidance For Patient Stipends?")
Does 'The Belmont Report' Provide Guidance For Patient Stipends?Consider implementing fair and flexible stipend models that account for individual burdens to enhance diversity, equity, and participation in clinical trials.
-
![It works great until protocol changes]( "It Works Great Until Your Protocol Changes")
It Works Great Until Your Protocol ChangesThe CEO of Korio discusses the challenges of change and how Korio's platform addresses every shifting protocols.
-
Faster Trial Planning and Site Selection4/15/2025
Address the challenges of identifying the most suitable trial sites and investigators while optimizing feasibility planning, reducing screen failure rates, and improving patient retention.
-
Human Abuse Potential: Participant Recruitment5/1/2026
Take a look at the strategies behind successful human abuse potential studies, from volunteer recruitment models to retention challenges, and how participant experience directly impacts data quality.
-
From Data Delays To Decision Speed7/31/2026
The biggest risk in modern trials isn’t missing data. It’s delayed insight. Discover how real-time intelligence helps teams act faster, reduce risk, and improve trial execution.
-
Achieving A 2.67x Reduction In Study Build Time For An Innovative Neuromodulation Study12/20/2024
This study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.
-
De-Risking Early-Stage Biotech: Turning Vision Into Venture Capital9/3/2025
For early-stage biotech companies, transforming a scientific breakthrough into an investable asset requires more than compelling data—it requires a clear product vision.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-953449116 clinical trial oversight]( "Smarter Oversight, Earlier Action")
When risk-based oversight is reduced to a compliance checkbox, critical signals can be missed and escalate into systemic issues.
-
![GettyImages-1174677845-blood work-blood tubes]( "Precision Kitting: Every Sample Matters, Every Detail Counts")
Precision starts at collection. The integrity of trial data depends on accurate, compliant, and traceable sample handling, but standard kitting isn’t built for the demands of biomarker-driven research.
-
![GettyImages- 1254443202 medical writing]( "Medical Writing Services To Support Every Submission Milestone")
Ensure accurate, compliant, and impactful documentation with Altasciences' experienced medical writers and regulatory experts.
-
![Rare Disease Clinical Trials – The Importance Of Rigorous Study Designs]( "Get Novel Infectious Disease Vaccines, Therapies To Market Faster")
Infectious diseases are a threat to global health and way of life everywhere. Time is of the essence when it comes to developing safe and effective infectious disease vaccines and treatments.
-
![Medicine-pills-tablets-GettyImages-545993684]( "Human Abuse Potential")
With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
